GC has been clear for a long time that Q4 is when it was happening and things are on track. He has consistently said that. I still expect it. All he has been saying for a while now, not just in tweets today, is that market conditions and reaction to share price could influence timing. He has always said that. I am also sure it depends on how well they can negotiate things behind the scenes with partners and knowing when the FDA will respond to ODD apps is tough. I would put a date on any potential future delay in uplist. I still expect it in Q4 and he stated again today things are in track.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links